AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30324839 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rehydration salts plus health education
Number of subjects: 105
Study 30324839 — intervention group
Group type: COMPARATOR
Intervention: Health education alone
Number of subjects: 105
Study 30324839 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rehydration salts
Number of subjects: 105
Study 28288435 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered program
Number of subjects: 317
Study 28288435 — intervention group
Group type: COMPARATOR
Intervention: Group-delivered program
Number of subjects: 317
Study 28288435 — intervention group
Group type: COMPARATOR
Intervention: Group-delivered program (engaged participants)
Number of subjects: 317
Study 24828247 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent‐Adolescent‐CBT (PA‐CBT)
Number of subjects: 24
Study 24828247 — intervention group
Group type: COMPARATOR
Intervention: Adolescent Only CBT (AO‐CBT)
Number of subjects: 24
Study 23384404 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin 125 mg four times/day
Number of subjects: 35
Study 23384404 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin 250 mg four times/day
Number of subjects: 35
Study 23384404 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 250 mg three times/day
Number of subjects: 35
Study 23384404 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 500 mg three times/day
Number of subjects: 35
Study 23384404 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole (any dose)
Number of subjects: 35
Study 21097838 — intervention group
Group type: EXPERIMENTAL
Intervention: Packed RBC transfusion (15 ml/kg) at high ('liberal') haematocrit thresholds
Number of subjects: 41
Study 21097838 — intervention group
Group type: EXPERIMENTAL
Intervention: Packed RBC transfusion (15 ml/kg) at low ('restrictive') haematocrit thresholds
Number of subjects: 41
Study 21097838 — intervention group
Group type: COMPARATOR
Intervention: Control group (high haematocrit threshold)
Number of subjects: 41
Study 21097838 — intervention group
Group type: COMPARATOR
Intervention: Control group (low haematocrit threshold)
Number of subjects: 41
Study 19255707 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation applied to the skin above the infrahyoid muscle, adjusted until muscle contraction occurred, with participants swallowing forcefully during stimulation.
Number of subjects: 16
Study 19255707 — intervention group
Group type: COMPARATOR
Intervention: Control group received stimulation adjusted to just above sensory threshold.
Number of subjects: 16
Study 16925686 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (combination of four probiotic strains)
Number of subjects: 61
Study 14660065 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate massage
Number of subjects: 36
Study 14660065 — intervention group
Group type: EXPERIMENTAL
Intervention: Light massage
Number of subjects: 36
Study 14660065 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibratory stimulation
Number of subjects: 36
Study 11328901 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 131
Study 11328901 — intervention group
Group type: COMPARATOR
Intervention: Alternative antihypertensive therapy (Control)
Number of subjects: 131
Study 9129633 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreservation without fetal calf serum (FCS)
Number of subjects: 21
Study 9129633 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreservation with fetal calf serum (FCS)
Number of subjects: 21
Study 9129633 — intervention group
Group type: COMPARATOR
Intervention: Unfrozen HMA
Number of subjects: 21
Study 9129633 — intervention group
Group type: COMPARATOR
Intervention: Unfrozen HCA
Number of subjects: 21
Study 8026202 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac output measurement at three insertion depths of the pulmonary artery catheter with different rates of flow into the introducer sheath
Number of subjects: 10
Study 8026202 — intervention group
Group type: EXPERIMENTAL
Intervention: Closer injection port to the introducer sheath and more open introducer sheath sidearm
Number of subjects: 10
Study 8026202 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold saline injection port of the pulmonary artery catheter downstream of the introducer sheath and closed introducer sidearm
Number of subjects: 10
Study 2690999 — intervention group
Group type: EXPERIMENTAL
Intervention: Minaprine (100 mg t.d.s. and 100 mg b.d.)
Number of subjects: 117
Study 2690999 — intervention group
Group type: COMPARATOR
Intervention: Mianserin (20 mg t.d.s.)
Number of subjects: 117
Study 962291 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous oestriol succinate therapy (2 mg/day) for three years
Number of subjects: 60
Study 962291 — intervention group
Group type: COMPARATOR
Intervention: Castration only
Number of subjects: 60
Study 962291 — intervention group
Group type: COMPARATOR
Intervention: Control group without hormone therapy
Number of subjects: 60
Study 31473331 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish-language self-help smoking cessation intervention (10 booklets, 9 pamphlets, and a booklet for family and friends mailed monthly over 18 months)
Number of subjects: 1417
Study 31473331 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (standard smoking cessation booklet developed by the National Cancer Institute)
Number of subjects: 1417
Study 28631003 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 320
Study 28631003 — intervention group
Group type: EXPERIMENTAL
Intervention: PT
Number of subjects: 320
Study 28631003 — intervention group
Group type: COMPARATOR
Intervention: Education
Number of subjects: 320
Study 28631003 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga and PT
Number of subjects: 320
Study 25996892 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin low dose (2 μg/kg)
Number of subjects: 30
Study 25996892 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin high dose (10 μg/kg)
Number of subjects: 30
Study 25996892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 23549694 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (VIB)
Number of subjects: 68
Study 23549694 — intervention group
Group type: COMPARATOR
Intervention: Balance training (BAL)
Number of subjects: 68
Study 21557814 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (intra-arterial thrombolysis with alteplase, possibly associated with mechanical clot disruption and/or retrieval)
Number of subjects: 350
Study 21557814 — intervention group
Group type: COMPARATOR
Intervention: Systemic intravenous thrombolysis with alteplase
Number of subjects: 350
Study 21557814 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 350
Study 19587620 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity epidural simulator
Number of subjects: 24
Study 19587620 — intervention group
Group type: COMPARATOR
Intervention: Low-fidelity model
Number of subjects: 24
Study 17563309 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled insulin
Number of subjects: 0
Study 17563309 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous insulin and oral agents
Number of subjects: 0
Study 15264265 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational videotape on return to sexual activity
Number of subjects: 115
Study 15264265 — intervention group
Group type: EXPERIMENTAL
Intervention: Written instructions and a videotape
Number of subjects: 115
Study 15264265 — intervention group
Group type: COMPARATOR
Intervention: Written instructions alone
Number of subjects: 115
Study 11440218 — intervention group
Group type: EXPERIMENTAL
Intervention: norfloxacin 400 mg b.i.d. for 10 d
Number of subjects: 171
Study 11440218 — intervention group
Group type: COMPARATOR
Intervention: ceftibuten 200 mg b.i.d. for 10 d
Number of subjects: 171
Study 10406416 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-evaluation in a chest pain clinic less than a week after discharge from hospital
Number of subjects: 858
Study 10406416 — intervention group
Group type: COMPARATOR
Intervention: Control group with no formalized follow-up
Number of subjects: 858
Study 10406416 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 858
Study 7800216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin (12 mg/kg)
Number of subjects: 9
Study 7800216 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (100 mg day 1 + 100 mg day 2)
Number of subjects: 9
Study 3056019 — intervention group
Group type: EXPERIMENTAL
Intervention: Hirschberg test
Number of subjects: 0
Study 3056019 — intervention group
Group type: COMPARATOR
Intervention: Alternate cover test
Number of subjects: 0
Study 3056019 — intervention group
Group type: COMPARATOR
Intervention: Photographic Hirschberg procedure
Number of subjects: 0
Study 29885858 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (2.0 mA anodal stimulation)
Number of subjects: 37
Study 29885858 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 37
Study 25686052 — intervention group
Group type: EXPERIMENTAL
Intervention: Active training group
Number of subjects: 0
Study 25686052 — intervention group
Group type: COMPARATOR
Intervention: Sham training group
Number of subjects: 0
Study 23349313 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower‐body graduated compression garment (GCG)
Number of subjects: 8
Study 23349313 — intervention group
Group type: COMPARATOR
Intervention: Sham condition (compression garment 1 size larger than recommended)
Number of subjects: 8
Study 23349313 — intervention group
Group type: COMPARATOR
Intervention: Control (running shorts)
Number of subjects: 8
Study 23349313 — intervention group
Group type: COMPARATOR
Intervention: All conditions (GCG, sham, control)
Number of subjects: 8
Study 21122176 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium physiologically based solution
Number of subjects: 1116
Study 21122176 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 1116
Study 18528671 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (SIT) for atopic dermatitis
Number of subjects: 0
Study 18528671 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (SIT) for food allergies
Number of subjects: 0
Study 18528671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17162712 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin acetate + combined estradiol/norethisterone acetate therapy (GA/CENT)
Number of subjects: 31
Study 17162712 — intervention group
Group type: COMPARATOR
Intervention: Goserelin acetate + placebo (GA/placebo)
Number of subjects: 31
Study 15018017 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose isotretinoin (0.15-0.40 mg/kg per day)
Number of subjects: 64
Study 15018017 — intervention group
Group type: COMPARATOR
Intervention: High-dose isotretinoin (0.5-1.0 mg/kg per day)
Number of subjects: 64
Study 15018017 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose isotretinoin
Number of subjects: 64
Study 10847215 — intervention group
Group type: EXPERIMENTAL
Intervention: T-ACASI interviewing
Number of subjects: 2881
Study 10847215 — intervention group
Group type: COMPARATOR
Intervention: Human interviewers
Number of subjects: 2881
Study 9166199 — intervention group
Group type: EXPERIMENTAL
Intervention: Upright position during delivery
Number of subjects: 517
Study 9166199 — intervention group
Group type: COMPARATOR
Intervention: Supine position during delivery
Number of subjects: 517
Study 7942583 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium alginate (7.5 g)
Number of subjects: 6
Study 2452915 — intervention group
Group type: EXPERIMENTAL
Intervention: Panzytrat 20,000
Number of subjects: 17
Study 2452915 — intervention group
Group type: COMPARATOR
Intervention: Two enzyme preparations tested
Number of subjects: 17
Study 2452915 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatic enzyme replacement therapy
Number of subjects: 17
Study 29478819 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestronidase alfa treatment for 24 weeks
Number of subjects: 12
Study 28679554 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey and calcium (whey+); 45-48 g/d
Number of subjects: 220
Study 28679554 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey; 45-48 g/d
Number of subjects: 220
Study 28679554 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy; 45-48 g/d
Number of subjects: 220
Study 28679554 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (control); 45-48 g/d
Number of subjects: 220
Study 26289639 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg Fe doses (twice-daily dosing)
Number of subjects: 54
Study 26289639 — intervention group
Group type: EXPERIMENTAL
Intervention: Doses ≥60 mg Fe
Number of subjects: 54
Study 26289639 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing doses of iron (40-240 mg)
Number of subjects: 54
Study 26289639 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dosages (40-80 mg Fe)
Number of subjects: 54
Study 24399321 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin care (SSC)
Number of subjects: 5
Study 24399321 — intervention group
Group type: COMPARATOR
Intervention: Incubator period after SSC
Number of subjects: 5
Study 21826576 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored education
Number of subjects: 515
Study 21826576 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 515
Study 21826576 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 515
Study 18317083 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9% saline and bupivacaine with adrenaline (1:500,000) infiltrated in one breast
Number of subjects: 50
Study 18317083 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline and bupivacaine infiltrated in the other breast
Number of subjects: 50
Study 16915063 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory imaging with CT
Number of subjects: 17
Study 16915063 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory imaging with CT
Number of subjects: 17
Study 14657863 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 85
Study 11074980 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic saphenous vein harvesting
Number of subjects: 90
Study 11074980 — intervention group
Group type: COMPARATOR
Intervention: Open saphenous vein harvesting
Number of subjects: 90
Study 11074980 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative sera
Number of subjects: 90
Study 11074980 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative sera
Number of subjects: 90
Study 8958488 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine 10%
Number of subjects: 99
Study 8958488 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine 1% and Lignocaine 4%
Number of subjects: 99
Study 1389521 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF x six (cyclophosphamide 100 mg/m2 orally on days 1‐14, methotrexate 40 mg/m2 intravenously on days 1 and 8, fluorouracil 600 mg/m2 intravenously on days 1 and 8 for six cycles)
Number of subjects: 622
Study 1389521 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF x 12 (same as above for twelve cycles)
Number of subjects: 622
Study 1389521 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + CMF x six (5000 cGy of postmastectomy regional radiotherapy followed by six cycles of CMF)
Number of subjects: 622
Study 1389521 — intervention group
Group type: COMPARATOR
Intervention: CMF x six
Number of subjects: 622
Study 3528494 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge base emphasizing disease groupings, symptom-disease associations, and clinical problem-solving heuristics
Number of subjects: 35
Study 3528494 — intervention group
Group type: COMPARATOR
Intervention: Knowledge base presented in a textbook format emphasizing pathophysiology
Number of subjects: 35
Study 29338584 — intervention group
Group type: EXPERIMENTAL
Intervention: betaHB salts (0.38 g kg body mass‐1) in plain water (3.8 mL kg body mass‐1)
Number of subjects: 19
Study 29338584 — intervention group
Group type: COMPARATOR
Intervention: plain water (3.8 mL kg body mass‐1)
Number of subjects: 19
Study 26536385 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied Tension (AT) instruction
Number of subjects: 244
Study 26536385 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation instruction
Number of subjects: 244
Study 26536385 — intervention group
Group type: EXPERIMENTAL
Intervention: Web browsing
Number of subjects: 244
Study 26536385 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 244
Study 24168836 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital camera (DC)
Number of subjects: 33
Study 24168836 — intervention group
Group type: COMPARATOR
Intervention: Paper diary (PD)
Number of subjects: 33
Study 22551127 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioiodine dose of 1.1 GBq
Number of subjects: 752
Study 22551127 — intervention group
Group type: COMPARATOR
Intervention: Radioiodine dose of 3.7 GBq
Number of subjects: 752
Study 22551127 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyrotropin-stimulation method using recombinant human thyrotropin
Number of subjects: 752
Study 22551127 — intervention group
Group type: COMPARATOR
Intervention: Thyrotropin-stimulation method using thyroid hormone withdrawal
Number of subjects: 752
Study 22551127 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of radioiodine (1.1 GBq and 3.7 GBq)
Number of subjects: 752
Study 22551127 — intervention group
Group type: EXPERIMENTAL
Intervention: Both thyrotropin-stimulation methods
Number of subjects: 752
Study 21265192 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus manipulative regulation of knee muscle balance
Number of subjects: 121
Study 21265192 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac Sodium Sustained Release Tablets
Number of subjects: 121
Study 18206735 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g ethylic alcohol (149 ml of Gordon's Gin)
Number of subjects: 30
Study 18206735 — intervention group
Group type: COMPARATOR
Intervention: 149 ml of water (placebo)
Number of subjects: 30
Study 16437674 — intervention group
Group type: EXPERIMENTAL
Intervention: Liniment levamisole
Number of subjects: 0
Study 14694695 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-held records
Number of subjects: 201
Study 14694695 — intervention group
Group type: COMPARATOR
Intervention: Control group (no patient-held records)
Number of subjects: 201
Study 10507150 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrostatic air cleaning technology (EAC)
Number of subjects: 0
Study 10507150 — intervention group
Group type: COMPARATOR
Intervention: Control (no EAC technology)
Number of subjects: 0
Study 8534699 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily dose gentamicin (40 mg/2 L dialysate)
Number of subjects: 73
Study 8534699 — intervention group
Group type: COMPARATOR
Intervention: Multiple-dose gentamicin (10 mg/2 L dialysate administered 4 times per day)
Number of subjects: 73
Study 8534699 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily dose gentamicin
Number of subjects: 73
Study 8534699 — intervention group
Group type: COMPARATOR
Intervention: Multiple-dose gentamicin
Number of subjects: 73
Study 1751456 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% bromovinyldeoxyuridine (BVDU)
Number of subjects: 60
Study 1751456 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% trifluorothymidine (TFT)
Number of subjects: 60
Study 6286517 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone administration for 3 days prior to the test
Number of subjects: 36
Study 6286517 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of 25 U of corticotropin 30 min pre-exercise
Number of subjects: 36
Study 30346554 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated prognostic model using high-dimensional electronic medical record data
Number of subjects: 12588
Study 30346554 — intervention group
Group type: COMPARATOR
Intervention: Published model using performance status, primary tumor site, and treated site
Number of subjects: 12588
Study 28426870 — intervention group
Group type: EXPERIMENTAL
Intervention: vCH 0.55% drops
Number of subjects: 31
Study 28426870 — intervention group
Group type: COMPARATOR
Intervention: CH 0.10% drops
Number of subjects: 31
Study 25414039 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin
Number of subjects: 22
Study 25414039 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 23653284 — intervention group
Group type: EXPERIMENTAL
Intervention: High Glycaemic Index (HGI) meals
Number of subjects: 14
Study 23653284 — intervention group
Group type: COMPARATOR
Intervention: Low Glycaemic Index (LGI) meals
Number of subjects: 14
Study 23653284 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy intake, energy expenditure, energy balance, resting metabolic rate
Number of subjects: 14
Study 21182171 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutter Valve™
Number of subjects: 8
Study 21182171 — intervention group
Group type: COMPARATOR
Intervention: Sham Flutter intervention
Number of subjects: 8
Study 19293784 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham acupuncture
Number of subjects: 289
Study 19293784 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 289
Study 17445066 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency TENS (4 Hz/200 micros)
Number of subjects: 66
Study 17445066 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency TENS (110 Hz/200 micros)
Number of subjects: 66
Study 17445066 — intervention group
Group type: COMPARATOR
Intervention: TENS (both Low and High frequency)
Number of subjects: 66
Study 15250431 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education and home physical therapy
Number of subjects: 70
Study 15250431 — intervention group
Group type: COMPARATOR
Intervention: Patient education only
Number of subjects: 70
Study 15250431 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and physical therapy
Number of subjects: 70
Study 15250431 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment modalities
Number of subjects: 70
Study 11772871 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/d)
Number of subjects: 33
Study 9651717 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy
Number of subjects: 11
Study 7865687 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UH) 50 IU/kg i.v. with protamine sulphate (PS) 1 mg/100 IU of heparin
Number of subjects: 50